Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Contos, 2004, The histologic spectrum of nonalcoholic fatty liver disease, Clin Liver Dis, 8, 481, 10.1016/j.cld.2004.04.013

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Wanless, 1990, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors, Hepatology, 12, 1106, 10.1002/hep.1840120505

Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193

Adams, 2005, The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies, J Hepatol, 42, 132, 10.1016/j.jhep.2004.09.012

Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327

Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, 38, 1449, 10.1016/j.hep.2003.09.022

Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084

Pinzani, 2008, Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography, Nat Clin Pract Gastroenterol Hepatol, 5, 95, 10.1038/ncpgasthep1025

Ratziu, 2006, Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease, BMC Gastroenterol, 6, 6, 10.1186/1471-230X-6-6

Guha, 2008, Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers, Hepatology, 47, 455, 10.1002/hep.21984

Huwart, 2007, Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index, Radiology, 245, 458, 10.1148/radiol.2452061673

Kawamoto, 2006, Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers, World J Gastroenterol, 12, 4325, 10.3748/wjg.v12.i27.4325

Yoneda, 2008, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD), Dig Liver Dis, 40, 371, 10.1016/j.dld.2007.10.019

Poynard, 2005, FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?, Expert Rev Mol Diagn, 5, 15, 10.1586/14737159.5.1.15

Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496

Rosenberg, 2004, Serum markers detect the presence of liver fibrosis: a cohort study, Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052

Ratziu, 2000, Liver fibrosis in overweight patients, Gastroenterology, 118, 1117, 10.1016/S0016-5085(00)70364-7

Suzuki, 2005, Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease, Liver Int, 25, 779, 10.1111/j.1478-3231.2005.01064.x

Sakugawa, 2005, Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease, World J Gastroenterol, 11, 255, 10.3748/wjg.v11.i2.255

Harrison, 2008, Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease, Gut, 57, 1441, 10.1136/gut.2007.146019

Sterling, 2006, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, 43, 1317, 10.1002/hep.21178

Vallet-Pichard, 2007, FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection, Hepatology, 46, 32, 10.1002/hep.21669

Schwimmer, 2005, Histopathology of pediatric nonalcoholic fatty liver disease, Hepatology, 42, 641, 10.1002/hep.20842

Cervantes, 1994, Comparison of timeline follow-back and averaging methods for quantifying alcohol consumption in treatment research, Assessment, 1, 23, 10.1177/1073191194001001004

Conigrave, 1995, The AUDIT questionnaire: choosing a cut-off score, Addiction, 90, 1349, 10.1111/j.1360-0443.1995.tb03552.x

Kokotailo, 2004, Validity of the alcohol use disorders identification test in college students, Alcohol Clin Exp Res, 28, 914, 10.1097/01.ALC.0000128239.87611.F5

Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701

Bonacini, 1997, Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection, Am J Gastroenterol, 92, 1302

Bourliere, 2006, Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies, J Viral Hepat, 13, 659, 10.1111/j.1365-2893.2006.00736.x

Islam, 2005, Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers, Scand J Gastroenterol, 40, 867, 10.1080/00365520510015674

Borroni, 2006, Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C, Aliment Pharmacol Ther, 24, 797, 10.1111/j.1365-2036.2006.03034.x

Blonsky, 2008, Review article: nonalcoholic fatty liver disease and hepatitis C virus—partners in crime, Aliment Pharmacol Ther, 27, 855, 10.1111/j.1365-2036.2008.03672.x

Kunde, 2005, Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women, Hepatology, 42, 650, 10.1002/hep.20818

Hanley, 1983, A method for comparing the area under the receiver operating curves derived from the same cases, Radiology, 148, 839, 10.1148/radiology.148.3.6878708

Escudero, 2008, Assessment of classification improvement in patients with Alzheimer's disease based on magnetoencephalogram blind source separation, Artif Intell Med, 43, 75, 10.1016/j.artmed.2008.01.001

Sahiner, 2008, Classifier performance estimation under the constraint of a finite sample size: Resampling schemes applied to neural network classifiers, Neural Netw, 21, 476, 10.1016/j.neunet.2007.12.012

Valkenborg, 2008, A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry, Stat Appl Genet Mol Biol, 7, Article12, 10.2202/1544-6115.1363

Rivera-Fernandez, 1998, The Apache III prognostic system: customized mortality predictions for Spanish ICU patients, Intensive Care Med, 24, 574, 10.1007/s001340050618

Mofrad, 2003, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229

Poynard, 2007, Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages, Clin Chem, 53, 1615, 10.1373/clinchem.2007.085795

Ratziu, 2007, Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia, Aliment Pharmacol Ther, 25, 207, 10.1111/j.1365-2036.2006.03182.x